Evidence map›Paper›PMID 42238969›Full record

ReviewPublic health weekly report2026

Operational Overview and Implementation Challenges of Misokkumteo, a National Tuberculosis Care Facility (2011-2024).

An-Yeol Lee, Jin-Hwan Jeon, Soonryu Seo, Seung Eun Lee

Abstract readReview
In one paragraph

Review in Public health weekly report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

An-Yeol LeeMisokkumteo, Seoul, Korea.ORCID https://orcid.org/0009-0000-7608-5934
Jin-Hwan JeonMisokkumteo, Seoul, Korea.ORCID https://orcid.org/0000-0002-5775-4108
Soonryu SeoDivision of Tuberculosis Policy, Department of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0000-0001-6252-8984
Seung Eun LeeDivision of Tuberculosis Policy, Department of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0009-0004-8650-5591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Homeless individuals form a vulnerable group for tuberculosis and require comprehensive, continuous patient care and support. This report describes the characteristics, treatment outcomes, and postdischarge support of residents at Misokkumteo, the only long-term tuberculosis care and support facility for homeless individuals in the Republic of Korea. Methods: A total of 458 residents were included, all admitted between 2011 and 2024. Their general characteristics, length of stay, treatment outcomes, and self-reliance after discharge were identified using facility records and follow-up data. Results: Of the total number of residents, 99.3% were male, and their mean age was 53 years. The average length of stay was 196 days, and the treatment success rate was 94.9%. Residents received health education and counseling on disease management and treatment adherence, including direct observation therapy, medical and social welfare linkage services, rehabilitation, and vocational support. Following their discharge, housing support, employment linkage, and social welfare enrollment were provided. Conclusions: Misokkumteo contributed to maintaining the continuum of care and supporting social reintegration among homeless tuberculosis patients. The expansion of community-based treatment support and financial assistance for comorbidity management is needed.

Indexed as

Homeless personsMisokkumteoTuberculosisVulnerable populations

Identifiers

PMID42238969
PMCPMC13228912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.